References
- Kershenobich D, Vargas F, Garcia-Tsao G, Tamayo R P, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988; 18: 1709–1713
- Sauerbruch T, Wotzka R, Kopcke W, et al. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med 1988; 19: 8–15
- Pascal J-P, Cales P. A Multicenter Group. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987; 317: 856–861
- Westaby D, Macdougall B RD, Williams R. Improved survival following injection sclerotherapy for esophageal varices: Final analysis of a controlled trial. Hepatology 1985; 5: 827–830
- Paquet K-J, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: A prospective controlled randomized trial. Hepatology 1985; 5: 580–583
- Korula J, Balart L A, Radvan G, et al. A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 1985; 5: 584–589
- Cello J P, Grendell J H, Crass R A, Weber T E, Trunkey DD. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. N Engl J Med 1987; 316: 11–15
- Cortez Pinto H, Ahrantes A, Esteves A V, Almeida H, Pinto Correia J. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am J Gastroenterol 1989; 84: 1239–1243
- Santangelo W C, Dueno MI, Estes BL, Krejs GJ. Prophylactic sclerotherapy of large esophageal varices. N Engl J Med 1988; 318: 814–818
- Russo A, Giannone G, Magnano A, Passanisi G, Longo C. Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: Preliminary results of a prospective controlled randomized trial. World J Surg 1989; 13: 149–153
- Kaplan M M, Ailing DW, Zimmerman HJ, et al. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 1986; 15: 1448–1454
- Kaplan MM. Methotrexate treatment of chronic cholestatic liver diseases: friend or foe?. Q J Med 1989; 72: 757–761
- Dickson ER. Treatment of primary biliary cirrhosis (PBC): Newer options and application of survival modeling. Abstract book of second international meeting of biliary club. BolognaItaly 1990
- Poupon R, Poupon R E, Calmus Y, Chretien Y, Ballet F, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?. Lancet 1987; 1: 834–836
- Leuschner U, Fischer H, Kurtz W, et al. Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial. Gastroenterology 1989; 97: 1268–1274
- Merigan T C, Poltkin G R, Davidson CS. Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding esophageal varices. N Engl J Med 1962; 266: 134–135
- Fogel M R, Knauer CM, Andres LL, et al. Continuous intravenous vasopressin in active upper gastrointestinal bleeding. Ann Intern Med 1982; 96: 565–569
- Tsai Y-T, Lay C-S, Lai K-H, et al. Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding esophageal varices. Hepatology 1986; 6: 406–409
- Groszmann R J, Kravetz D, Bosch J, et al. Nitroglycerin improves hemodynamic response to vasopressin in porta] hypertension. Hepatology 1982; 2: 757–762
- Gimson A ES, Westaby D, Hegarty J, Watson A, Williams R. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology 1986; 6: 410–413
- Freeman J G, Cobden I, Record CO. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989; 11: 58–60
- Walker S, Stiehl A, Raedsch R, Kommerell B. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology 1986; 6: 112–115
- Kravetz D, Bosch J, Teres J, Bruix J, Rimola A, Rodes J. Comparison of intravenous somatostatin and vasopressin infusions in the treatment of acute variceal hemorrhage. Hepatology 1984; 4: 442–446
- Jenkins S A, Baxter J N, Corbett W, Devitt P, Ware J, Shields R. A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haeorrhage. Br Med J 1985; 290: 275–278
- Teres J, Cecilia A, Bordas J M, Rimola A, Bru C, Rodes J. Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 1978; 75: 566–569
- Mitchell K, Silk D A, Williams R. Prospective comparison of two Sengstaken tubes in the management of patients with variceal hemorrhage. Gut 1980; 21: 570–573
- Moreto M, Zaballa M, Bernal A, Ibanez S, Ojembarrena E, Rodriguez A. A randomized trial of tamponade or sclerotherapy as immediate treatment for bleeding esophageal varices. Surg Gynecol Obstet 1988; 167: 331–334
- Westaby D, Hayes P C, Gimson A ES, Poison R J, Williams R. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989; 9: 274–277
- Burroughs A K, Hamilton G, Phillips A, Mezzanotte G, McLntyre N, Hobbs K EF. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989; 321: 857–862
- Infante-Rivard C, Esnaola S, Villeneuve J-P. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: A metaanalysis. Gastroenterology 1989; 96: 1087–1092
- Lebrec D, Poynard T, Bernuau J, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355–358
- Garden O J, Mills P R, Birnie G G, Murray G D, Carter DC. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. Gastroenterology 1990; 98: 185–190
- Starzl T E, Demetris A J, Van Thiel D. Liver transplantation. N Engl J Med 1989; 321: 1014–1022; 1092–1099
- Kjaergaard J, Fischer A, Miskowiak J, Lindahl F, Baden H. Sclerotherapy of bleeding esophageal varices. Scand J Gastroenterol 1982; 17: 363–367
- Khargi K, Jansen P LM, Rauws E AJ, Tytgat G NJ. De behandeling van bloedingen uit slokdarm varices met endoscopische sclerotherapie. Ned Tijdschr Geneeskd 1988; 132: 2423–2427
- O'Connor K W, Lehman G, Yune H, et al. Comparison of three nonsurgical treatments for bleeding esophageal varices. Gastroenterology 1989; 96: 899–906
- Garrett K O, Reilly J J, Schade R R, Van Thiel DH. Bleeding esophageal varices: Treatment by sclerotherapy and liver transplantation. Surgery 1988; 104: 819–823
- Sbderlund C. Long-term survivors after variceal haemorrhage. Follow-up of a controlled study of endoscopic sclerotherapy versus conservative management. Scand J Gastroenterol 1987; 2: 665–671
- Terblanche J, Bornman P C, Kahn D, et al. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. Lancet 1983; 2: 1328–1332
- Barsoum M S, Bolous F I, El-Rooby A A, Rizk-Allah M A, Ibrahim AS. Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg 1982; 69: 76–78
- The Copenhagen Esophageal Project VaricesSclerotherapy.Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med 1984; 311: 1594–1600